Narcolepsy Drugs Market
Increase in prevalence of narcolepsy globally and rise in awareness regarding the importance of early diagnosis of narcolepsy play a major role in the growth
Narcolepsy Drug Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, & Other) & Therapeutics Type (Tricyclic Antidepressant, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, & Other)” Mangesh PanhalePORTLAND, OR, UNITED STATES, December 12, 2020 /EINPresswire.com/ UPDATE AVAILABLE ON-DEMAND The narcolepsy drugs market was pegged at $2.43 billion in 2018 and is projected to reach $5.36 billion by 2026, registering a CAGR of 10.3% from 2019 to 2026. Rise in the global prevalence of narcolepsy, presence of reimbursement policies regarding narcolepsy, and narcolepsy awareness programs and services have boosted the growth of the narcolepsy drugs market. However, adverse effects and risks related to narcolepsy drugs and delayed diagnosis or mi